Cargando…
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
BACKGROUND: The incidence of malaria in the Americas has decreased markedly in recent years. Honduras and the other countries of Mesoamerica and the island of Hispaniola have set the goal of eliminating native malaria by the year 2020. To achieve this goal, Honduras has recently approved national re...
Autores principales: | Avalos, Sara, Mejia, Rosa E., Banegas, Engels, Salinas, Cesar, Gutierrez, Lester, Fajardo, Marcela, Galo, Suzeth, Pinto, Alejandra, Mejia, Angel, Fontecha, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225638/ https://www.ncbi.nlm.nih.gov/pubmed/30409136 http://dx.doi.org/10.1186/s12936-018-2564-2 |
Ejemplares similares
-
Modelling primaquine-induced haemolysis in G6PD deficiency
por: Watson, James, et al.
Publicado: (2017) -
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
por: Chu, Cindy S., et al.
Publicado: (2018) -
Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens
por: Chu, Cindy S., et al.
Publicado: (2017) -
Comparison of molecular tests for the diagnosis of malaria in Honduras
por: Fontecha, Gustavo A, et al.
Publicado: (2012) -
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
por: Chu, Cindy S., et al.
Publicado: (2019)